Skip directly to Accessibility Notice

How to Purchase

PPH
VanEck Vectors Pharmaceutical ETF

Fund Description

VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH
  • Exchange

    NASDAQ
  • Commencement

    12/20/2011
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    Bank of New York Mellon
  • Index Ticker

    MVPPHTR
  • Index Rebalancing

    Quarterly

 
as of 10/21/19

  • 30-Day SEC Yield1

    1.54%
  • Total Net Assets

    $174.5M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.43%
  • Net Expense Ratio/TER2

    0.36%
  • Distribution Frequency

    Quarterly
  • Next Distribution Date

    12/27/2019

Index Key Points

Underlying Index: MVIS US Listed Pharmaceutical 25 Index (MVPPHTR) 

The Index comprises:

U.S. exchange-listed companies that derive most of their revenues from pharmaceuticals, including companies engaged primarily in research and development as well as production, marketing and sales of pharmaceuticals

Companies initially eligible for inclusion in Index:

  • Principally engaged in the pharmaceutical industry, deriving greater than 50% of revenues from it
  • Market cap exceeding $150 million
  • Three-month average-daily-trading volume of at least $1 million
  • At least 250,000 shares traded per month

Index provider:

MV Index Solutions 

Index Profile

  • Ticker

    MVPPHTR
  • Inception Date

    08/12/2011
  • Rebalance Frequency

    Quarterly

Index Top 10 Constituents (%) as of 09/30/19 Download All Index Constituents

Total Constituents: 25
Swipe
to view
full data
Constituent Name
Ticker
Weightings (%)
Abbvie Inc
ABBV US
5.52
Sanofi-Adr
SNY US
5.45
Astrazeneca Plc-Spons Adr
AZN US
5.38
Glaxosmithkline Plc-Spon Adr
GSK US
5.32
Novo-Nordisk A/S-Spons Adr
NVO US
5.20
Eli Lilly & Co
LLY US
5.16
Merck & Co. Inc.
MRK US
5.12
Novartis Ag-Adr
NVS US
5.04
Johnson & Johnson
JNJ US
5.02
Pfizer Inc
PFE US
4.96
Top 10 Total (%) 52.17
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Index Country Weightings (%) as of 09/30/19

  • Country

    Weightings (%)
  • United States

    61.7
  • United Kingdom

    12.2
  • France

    5.4
  • Denmark

    5.2
  • Switzerland

    5.0
  • Japan

    4.6
  • Israel

    3.3
  • Ireland

    2.5

Index Sector Weightings (%) as of 09/30/19

  • Sector

    Weightings (%)
  • Health Care

    100.0